Late last year, we reported on the Women in AI Healthcare event – hosted by Real Chemistry in collaboration with Pharma Brands – which brought together a dynamic group of female leaders to discuss the transformative role of artificial intelligence (AI) in life sciences. The event was not just a showcase of innovation, but a call to action: to ensure women are not only present, but pivotal in shaping the future of AI in healthcare.
This June marked the third such Women in AI event, taking place at a time when AI in medicine has progressed from pilot to infrastructure. Guest female speakers included: Dr Anushka Patchava, chief clinical & innovation officer, Cignpost; Nora Lamoudi-Sutcliffe, senior commercial manager, Microsoft; and Eleanor Barr, AI product manager, GSK.
Pharma Brands’ intention, as stated by the event’s director, Kate Eversole, is still to upskill women in life sciences in AI, yet, the onus in June was somewhat less on that determined female placement in and working with AI – and instead concentrated more on AI’s overall positioning within the sector as a whole, both in terms of machine in lieu and machine alongside human. In this way, Women in AI became a platform for female leaders to discuss and learn more about AI in their field today.
Read more at: https://pharmaphorum.com/deep-dive/women-and-pharma-ai-where-are-we-now
